Alexander N. Vanderbilt

发表

ImmunoPET imaging of phosphatidylserine in pro-apoptotic therapy treated tumor models.

Judith E. Flores, A. Ashkenazi, Simon-Peter Williams, 2013, Nuclear medicine and biology.

The Effects of Anesthetic Agent and Carrier Gas on Blood Glucose and Tissue Uptake in Mice Undergoing Dynamic FDG-PET Imaging: Sevoflurane and Isoflurane Compared in Air and in Oxygen

Judith E. Flores, Simon-Peter Williams, Leanne M. McFarland, 2008, Molecular Imaging and Biology.

ImmunoPET helps predicting the efficacy of antibody-drug conjugates targeting TENB2 and STEAP1

Jeffrey T. Lau, Judith E. Flores, Simon-Peter Williams, 2016, Oncotarget.

Site-specifically 89Zr-labeled monoclonal antibodies for ImmunoPET.

Judith E. Flores, Simon-Peter Williams, A. Ogasawara, 2010, Nuclear medicine and biology.

Supplementation of nicotinic acid with NAMPT inhibitors results in loss of in vivo efficacy in NAPRT1-deficient tumor models.

Leslie B. Lee, D. Sampath, P. Jackson, 2013, Neoplasia.

A modular platform for the rapid site-specific radiolabeling of proteins with 18F exemplified by quantitative positron emission tomography of human epidermal growth factor receptor 2.

Judith E. Flores, Simon-Peter Williams, A. Ogasawara, 2009, Journal of medicinal chemistry.

University of Groningen ImmunoPET helps predicting the efficacy of antibody-drug conjugates targeting TENB2 and STEAP1 Williams,

Jeffrey T. Lau, Simon-Peter Williams, M. Go, 2016 .

Abstract 964: Inhibiting glycolysis with an LDHA inhibitor: A new solution to an old problem

Marie Evangelista, G. Hatzivassiliou, D. Sampath, 2014 .

Preparation and evaluation of L- and D-5-[18F]fluorotryptophan as PET imaging probes for indoleamine and tryptophan 2,3-dioxygenases.

Sharla L. White, W. Sandoval, G. Hatzivassiliou, 2017, Nuclear medicine and biology.

Preclinical Efficacy of an Antibody–Drug Conjugate Targeting Mesothelin Correlates with Quantitative 89Zr-ImmunoPET

Simon-Peter Williams, R. Firestein, A. Ogasawara, 2016, Molecular Cancer Therapeutics.

Evaluation of a 3-hydroxypyridin-2-one (2,3-HOPO) Based Macrocyclic Chelator for 89Zr4+ and Its Use for ImmunoPET Imaging of HER2 Positive Model of Ovarian Carcinoma in Mice

Simon-Peter Williams, A. Ogasawara, D. Magda, 2016, Theranostics.

Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition.

M. Belvin, A. Daemen, BinQing Wei, 2016, Nature chemical biology.

The development of peptide-based tools for the analysis of angiogenesis.

Judith E. Flores, K. Deshayes, Simon-Peter Williams, 2011, Chemistry & biology.

Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake

Zhijun Tang, Z. Modrušan, J. Zha, 2008, Molecular Cancer Therapeutics.

Limitations to the application of molecularly targeted cancer therapies are the inability to accurately match patient with effective treatment and the absence of a prompt readout of posttreatment response

Judith E. Flores, K. Deshayes, Simon-Peter Williams, 2011 .

PET of Glial Metabolism Using 2-18F-Fluoroacetate

Judith E. Flores, N. van Bruggen, F. Peale, 2009, Journal of Nuclear Medicine.

Preclinical Efficacy of an Antibody–Drug Conjugate Targeting Mesothelin Correlates with Quantitative 89Zr-ImmunoPET

Simon-Peter Williams, R. Firestein, A. Ogasawara, 2016, Molecular Cancer Therapeutics.

A modular platform for the rapid site-specific radiolabeling of proteins with 18F exemplified by quantitative positron emission tomography of human epidermal growth factor receptor 2.

Judith E. Flores, Simon-Peter Williams, A. Ogasawara, 2009, Journal of medicinal chemistry.